Recruiting OBSERVATIONAL NCT05808205

An Open, Non-comparative, Single-centre Post Marketing Clinical Followup (PMCF) Investigation to Evaluate Performance and Safety of the ALIAXIN Fillers Used as Intended

An Open, Non-comparative, Single-centre Post Marketing Clinical Follow-up (PMCF) Investigation to Evaluate Performance and Safety of the ALIAXIN Fillers Used as Intended

Sponsor: Rose Pharma SA

Conditions Esthetics

Interventions • ALIAXIN EV: Essential Volume • ALIAXIN FL: Lips • ALIAXIN SR: Shape & Restore • ALIAXIN GP: Global Performance • ALIAXIN LV: Lips Volume

Updated 4 times since 2023 Last updated: Apr 23, 2024 Started: Jun 30, 2021 Primary completion: Jun 30, 2025 Completion: Jun 30, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Esthetics, this trial is actively recruiting participants. The trial is conducted by Rose Pharma SA and has accumulated 4 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
May 2024 — Jul 2024 [monthly]

Recruiting
May 2023 — May 2024 [monthly]

Recruiting

First recorded

Jun 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Rose Pharma SA

Data source: Rose Pharma SA

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Milan, Italy